Navigation Links
Study Challenges Potassium Guidelines for Heart Attack Patients
Date:1/10/2012

TUESDAY, Jan. 10 (HealthDay News) -- Heart attack patients whose blood potassium levels are within a certain range are less likely to die than those with levels of the mineral below or above that range, says a new study that challenges current recommendations for potassium levels in heart attack patients.

Researchers looked at data from nearly 39,000 heart attack patients admitted to 67 U.S. hospitals between 2000 and 2008. Of those patients, nearly 7 percent died while they were hospitalized.

The death rate for patients with blood potassium levels of between 3.5 and less than 4 mEq/L (milliEquivalents per liter) was 4.8 percent, about the same as the 5 percent death rate among those with levels of 4 mEq/L to less than 4.5 mEq/L.

But mortality rose to 10 percent for those with levels of 4.5 to less than 5 mEq/L, and was even higher for those with levels greater than 5 mEq/L, the investigators found.

Patients with potassium levels of less than 3.5 mEq/L also had a higher death rate than those with levels of between 3.5 and less than 4.5 mEq/L, Dr. Abhinav Goyal, of the Emory Rollins School of Public Health in Atlanta, and colleagues, reported in the study published in the Jan. 11 issue of the Journal of the American Medical Association.

Currently, professional societies and experts recommend that potassium levels in heart attack patients should be maintained between 4.0 and 5.0 mEq/L or even 4.5 to 5.5 mEq/L, the researchers noted.

"In conclusion, our large study of patients with AMI [acute myocardial infarction, or heart attack] challenges current clinical practice guidelines that endorse maintaining serum potassium levels between 4.0 and 5.0 mEq/L," the study authors wrote.

The guidelines are based on small, older studies that focused only on ventricular arrhythmias and not mortality, and were conducted before the routine use of beta-blockers, treatments to quickly clear blockages and restore blood flow, and other treatment advances, the researchers said.

"Our data suggest that the optimal range of serum potassium levels in AMI patients may be between 3.5 and 4.5 mEq/L and that potassium levels of greater than 4.5 mEq/L are associated with increased mortality and should probably be avoided," the study authors noted.

In an accompanying editorial, Dr. Benjamin Scirica and Dr. David Morrow of Brigham and Women's Hospital and Harvard Medical School wrote that proving maintaining certain potassium levels prevents deaths would require a clinical trial that randomly assigns patients to different treatments, which is unlikely to ever be done.

"Thus, decisions about care must be formulated on the basis of best available information," the editorialists wrote.

Given that it is inexpensive and relatively low-risk, it's "reasonable" to avoid abnormally low potassium levels of less than 3.5 mEq/L in heart attack patients.

"However, based on the report by Goyal [and colleagues], viewed together with previous smaller studies . . . routinely targeting levels greater than 4.5 mEq/L, do not appear justified."

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart attack.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, Jan. 10, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Lower risk of death linked with access to key attributes of primary care, UC Davis study shows
2. Diabetes study shines spotlight on lifestyle interventions
3. Grief Is a Real Heartbreaker, Study Finds
4. Study finds federal amendments increased gun sales diverted to criminals
5. Nicotine Patches, Gums Wont Help Smokers Quit Long-Term: Study
6. Power of Acupuncture to Ease Migraines Questioned in Study
7. Exercise May Help Those at Higher Risk for Alzheimers: Study
8. Short Delay in Treating Blood Pressure Safe for Diabetics: Study
9. New study supports view that Lewy bodies are not the primary cause of cell death in PD
10. PSA Test for Prostate Cancer Doesnt Save Lives: Study
11. Study shows no evidence of a mortality benefit to PSA screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology: